Farthing M F, Dick A P, Heslop G, Levene C I
Gut. 1978 Aug;19(8):743-7. doi: 10.1136/gut.19.8.743.
Prolyl hydroxylase activity in rectal mucosa was found to be significantly greater in 11 patients with Crohn's disease than in 11 control subjects with the irritable bowel syndrome and 16 patients with ulcerative colitis (P less than 0.005). Seven of the patients with Crohn's disease had a histologically normal rectum. This abnormality in apparently normal mucosa supports the concept that Crohn's disease is a 'continuous' disease of the gastrointestinal tract. Although there was no significant difference in prolyl hydroxylase activity between control subjects and patients with ulcerative colitis, those patients with quiescent disease tended to have lower values than those with active mucosal inflammation. Prolyl hydroxylase activity could not, however, be detected in the sera of either healthy control subjects or patients with inflammatory bowel disease.
研究发现,11例克罗恩病患者直肠黏膜中的脯氨酰羟化酶活性显著高于11例肠易激综合征对照受试者及16例溃疡性结肠炎患者(P<0.005)。7例克罗恩病患者的直肠组织学检查正常。明显正常的黏膜出现这种异常情况支持了克罗恩病是一种胃肠道“连续性”疾病的概念。虽然对照受试者与溃疡性结肠炎患者之间的脯氨酰羟化酶活性无显著差异,但病情静止的患者其酶活性值往往低于有活动性黏膜炎症的患者。然而,在健康对照受试者或炎症性肠病患者的血清中均未检测到脯氨酰羟化酶活性。